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SUMMARY
DACH1 abundance is reduced in human malignancies, including breast cancer. Herein DACH1 was detected among multipotent fetal
mammary stem cells in the embryo, among mixed lineage precursors, and in adult basal cells and (ERa+) luminal progenitors. Dach1
gene deletion at 6 weeks in transgenic mice reduced ductal branching, reduced the proportion of mammary basal cells (Lin CD24med
CD29high) and reduced abundance of basal cytokeratin 5, whereas DACH1 overexpression induced ductal branching, increased Gata3
andNotch1, and expandedmammosphere formation in LA-7 breast cells.Mammary gland-transforming growth factor b (TGF-b) activity,
known to reduce ductal branching and to reduce the basal cell population, increased upon Dach1 deletion, associated with increased
SMAD phosphorylation. Association of the scaffold protein Smad anchor for receptor activation with Smad2/3, which facilitates
TGF-b activation, was reduced by endogenous DACH1. DACH1 increases basal cells, enhances ductal formation and restrains TGF-b
activity in vivo.
INTRODUCTION
TheDrosophila dac gene is a key member of the retinal deter-
mination gene network, which also includes eyes absent,
eyeless, twin of eyeless, teashirt, and sine oculis. Initially cloned
as a dominant inhibitor of a hyperactive egfr allele in
Drosophila, dac interacts with the epidermal growth factor re-
ceptor, decapentaplegic, andWingless pathways (Chenet al.,
1997, 1999). Dac functions to promote organismal develop-
ment (Davis and Rebay, 2017), andDacmutant flies have at-
retic organs (Davis and Rebay, 2017). Reduced DACH1 (the
mammalian ortholog of Dac) expression has been observed
in several malignancies including breast, prostate, lung,
and endometrial cancer (Chen et al., 2013; Nan et al.,
2009; Wu et al., 2006, 2009, 2013, 2014, 2015) (reviewed
inWu et al., 2015). Clinical studies have demonstrated a cor-
relation between poor prognosis and reduced expression of
DACH1 in breast cancer (Wu et al., 2006), and DACH1 re-
expression was sufficient to inhibit breast cancer tumor
metastasis in mice (Wu et al., 2008). The mammalian
DACH1 regulates expression of target genes in part through
intrinsic DNA sequence-specific binding to Forkhead bind-
ing sites and in part through interacting with DNA-binding
transcription factors (c-Jun, SMADs, Six, and ERa) (Popov
et al., 2009; Wu et al., 2006, 2009; Zhou et al., 2010b).
Dach1homozygous nullmice die at birth, indicating that
DACH1 governs essential functions in the organism; how-
ever, no morphologic and metabolic alterations have been
observed in the analyzed organs (Davis et al., 2001). Given
the precedent forDac promoting organismal development,
we sought to define the role for DACH1 function in normal
development by examining the role of DACH1 in normal
post-natal mammary gland development. Given the
importance of mammary stem cells in normal mammary
gland development (Visvader and Stingl, 2014), and the
prior studies demonstrating that DACH1 restrains breast
cancer stem cell expansion (Wu et al., 2011), we conducted
careful analysis of the mammary gland developmental hi-
erarchy through generating temporally regulated Dach1fl/fl
transgenics.
The current studies were conducted to determine the role
of DACH1 in normal mammary gland development. These
studies revealed an unexpected role for DACH1 to expand
the murine mammary gland progenitor cell pool, and to
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promote ductal formation. We show that endogenous
DACH1 restrains transforming growth factor b (TGF-b)
signaling in the murine mammary gland and show
that Dach1 governs SARA (also known as the zinc finger
FYVE domain-containing protein 9 [ZFYVE9]) abundance
and binding to Smad2/3. Given the importance of TGF-b
signaling in development and disease, the finding herein
that endogenous DACH1 restrains TGF-b signaling in vivo
may have broad importance to human disease.
RESULTS
Temporally Regulated Excision of the Dach1 Gene in
the Murine Mammary Gland Reduces Cell
Proliferation and Ductal Branching
To examine the physiological role of DACH1 in post-natal
mammary gland development, transgenic mice were devel-
oped inwhichDach1fl/fl transgenics (Chen et al., 2015) were
intercrossed with the ROSA26CreERT2 transgenics. This
mouse strain expresses Cre-ERT2 from the ubiquitously ex-
pressed ROSA26 locus. Cre activity utilizes a mutant estro-
gen hormone-binding domain (ERT) to keep Cre inactive
unless the non-steroidal estrogen analog 4-hydroxytamox-
ifen is present. To follow the efficiency of temporal and
spatial regulation of Cre recombination in vivo and in pri-
mary cells derived from these mice, bitransgenic mice
were intercrossed with double-fluorescent Cre reporter
mice (ROSA26-mTmGfl/fl). The ROSA26-mTmGfl/fl trans-
genics express membrane-targeted tandem dimer Tomato
(mT), and after Cre-mediated excision express membrane-
targeted GFP (mG) (Muzumdar et al., 2007) (Figure S1A).
Tri-transgenic mice at 6 weeks of age were treated with a
pulse of tamoxifen and analyzed after a subsequent
2.5 months (Figure 1A). Previous studies had shown that
this dose of tamoxifen was without effect on mammary re-
populating numbers or on pubertal ductal development at
this time of analysis (Shehata et al., 2014). Furthermore,
comparison was made herein between tamoxifen-treated
transgenics and tamoxifen-treated control transgenics
throughout to avoid any potential independent effect of
tamoxifen. Genomic DNA analysis of these mice demon-
strated the excision of the first exon of Dach1 (Figure S1B).
Mammary gland fluorescence without tamoxifen was red
throughout the mammary gland and epithelial cells (Fig-
ure 1B).Dach1wt/wt-ROSA26CreERT2mice, which were treated
with tamoxifen as a control in the studies, showed efficient
excision of the mT transgene and conversion to green fluo-
rescence throughout the mammary gland, without alter-
ation in Dach1 abundance (Figure 1B). Treatment of
Dach1fl/fl-ROSA26CreERT2 mice with tamoxifen resulted in
the induction of GFP in the mammary gland (Figure 1Bf
versus Bi Bl) andDACH1 protein, identified by immunohis-
tochemistry as primarily in the basal cells, was abrogated
upon tamoxifen treatment (Figure 1C).
DACH1 Is Expressed in Multipotent Fetal Mammary
Stem Cells and in Both the Adult Basal and ERa+
Luminal Cells
In order to examine the expression of Dach1 by mammary
gland cell type, we interrogated two recently published sin-
gle-cell RNA sequencing (scRNA-seq) studies that had iden-
tified mammary gland cellular subtypes (Bach et al., 2017;
Giraddi et al., 2018). scRNA-seq transcriptomes annotated
by stage of development were generated from Epcam+
mammary epithelial cells (MECs), derived from developing
(embryonic day 16 [E16] and E18), post-natal day (P4) and
adult mouse mammary tissues (Giraddi et al., 2018) (Fig-
ure 2A). The accession number for these data is GEO:
GSE106273 and GEO: GSE111113. Relatedness of individ-
ual cell transcriptomes was plotted according to diffusion
components (DCs) using the webtool (http://uofuhealth.
utah.edu/huntsman/labs/spike/d3.php) as previously
described (Giraddi et al., 2018). The diffusionmap provides
a noise-tolerant, nonlinear dimensionality reduction
method, revealing a global topology of the data based on
local similarities between individual Epcam+ MECs. In
this map, DC1 reflects a continuum of relative basal to
luminal character. DC2 reflects developmental time from
primitive (E16 and E18) at one extreme to P4 to adultmam-
mary cells at the other extreme of the DC2 axis. The abun-
dance of Dach1 transcripts was then assessed in the
diffusion map, in order to show the correlation with stage
of development and relative abundance in the luminal
versus basal subtypes (Figure 2B). Dach1 expression was
detected in early developmental stages including among
Figure 1. Inducible Dach1 Deletion in Mouse Mammary Gland
(A) Schematic representation of the tamoxifen treatment schedule for the multigenic Dach1 transgenics (Dach1fl/flROSA26CreERT2/mT-mGfl).
(B) Fluorescence microscopy showed the tamoxifen-induced Cre recombinase activity by Tomato-GFP color transformation. (a–c)
Dach1fl/wtROSA26wt/CreERT2mammary gland without tamoxifen treatment (negative control without Cre reporter and Cre induction) showing
GFP (mG) and tomato red fluorescence (mT) are both negative. (b–f) Dach1fl/wtROSA26CreERT2/mTmGfl mammary gland without tamoxifen
treatment (negative control without Cre induction) showing presence of mT without mG. (g–i) Dach1wt/wt ROSA26CreERT2/mTmGfl and (j–l)
Dach1fl/flROSA26CreERT2/mTmGfl mammary gland with tamoxifen treatment used for the Dach1 deletion mice analysis shows strong mG and
weak mT. The combined images showing mT to mG switch in the mammary ducts after tamoxifen treatment. (C) Immunohistochemical
staining for DACH1 protein in the mammary gland of the treated mice (Dach1wt/wtROSA26CreERT2/mTmGfl and Dach1fl/flROSA26CreERT2/mTmGfl).
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multipotent fetal mammary stem cells (fMaSCs) in the em-
bryo andmixed lineage precursors (MMPr) prior to puberty
(Figure 2B). Dach1 expression was also detected in adult
basal cells and ERa+ luminal progenitors.
We next assessed Dach1 transcript abundance in a sec-
ond distinct transcriptomic analysis. The second study
determined the gene expression profile of MECs across
four adult developmental stages; nulliparous, mid gesta-
tion, lactation, and post involution (Bach et al., 2017).
The analysis of 23,184 adult cells identified 15 clusters
representing different transcriptional cell states (Fig-
ure 2C). Dach1 gene expression was detectable primarily
in presumptive basal and myoepithelial cells (clusters
C12, C13, and C14), and to a lesser degree also in luminal
ERa+ (cluster C3) and luminal progenitor clusters (C6/7)
(Figures 2D–2F).
Collectively these studies are consistent between
distinct datasets and illustrate that Dach1 is expressed
in fMaSCs and in both the adult basal and ERa+ luminal
cells.
DACH1 Promotes Mammary Gland Stem Cell and
Basal/Myoepithelial Cell Expansion
To determine the functional consequence of Dach1 gene
deletion, cellular proliferation was assessed using Ki-67
immunohistochemistry. Ki-67 staining was reduced >75%
upon excision of the Dach1 gene (Figures 3A and 3B).
Apoptosis, as assessed by TUNEL staining, was very low
in control mice and was not affected by Dach1 deletion.
(Figures S2A and S2C). Treatment of tissues from Dach1
deletion mice (Dach1fl/fl; ROSA26mTmGfl/Cre-ERT2 + tamox-
ifen) with DNase1, as a form of positive control, induced
TUNEL staining in all the epithelial cells (Figures S2B and
S2C). Mammary squashes were prepared (Figures S3A and
S3B). A careful counting of branches revealed a significant
decrease in branching in the Dach1/ mammary gland
(Figure 3C).
To determine the role of endogenous DACH1 on the pro-
portion of breast cellular subtypes, fluorescence-activated
cell sorting (FACS) analysis was conducted on the mam-
mary gland from transgenic mice (Figure 3D). To enrich
for basal cells, Lin cells were selected (Figures 3D and
3E), with subsequent gating for CD29high and CD24medium
(basal) cells from tamoxifen-treated control (Dach1wt/wt-
Rosa26mTmGfl/Cre-ERT2) and Dach1fl/fl transgenic (Dach1fl/fl-
Rosa26mTmGfl/Cre-ERT2) mice (Figure 3F). Several studies
have shown the multilineage potential of cells in this sub-
population (Shackleton et al., 2006; Visvader and Stingl,
2014). This population, herein referred to as basal cells,
has previously been shown to be enriched with bipoten-
tial mammary stem cells (MaSCs) and gives rise to unipo-
tent stem cells or long-lived progenitors for the basal/
myoepithelial and luminal lineages (Visvader and Clevers,
2016). The relative proportion of Lin CD24med CD29high
was reduced >40% in Dach1/ mammary gland (Fig-
ure 3D). Quantitation of the additional cell subtypes, based
on epitope markers and FACS analysis revealed an increase
in the luminal epithelial pool (CD24high CD29low) in the
Dach1/ mammary gland (Figure 3G).
To examine further the impact of endogenous DACH1
on the development of the basal versus the luminal epithe-
lial cells, we conducted immunofluorescence analysis of
the mammary glands using traditional cytokeratin lineage
markers. Cytokeratin 5 (CK5) was used to identify basal
epithelial cells, and CK8 was used for the identification of
luminal epithelial cells. In the Dach1/ mammary gland
epithelial cells, the relative abundance of CK5 was reduced
and the relative abundance of CK8 was increased (Figures
4A and S4).
DACH1 Enhances Abundance of Genes Governing
Ductal Branching
Because DACH1 loss reduced mammary duct branching,
we next determined the effect of endogenous DACH1 on
Figure 2. Dach1 RNA Transcripts in Mammary Epithelial Cells during Development
(A) Diffusion map of single-cell RNA sequencing (scRNA-seq) transcriptomes annotated by stage of development. Epcam+ mammary
epithelial cells (MECs) were derived from developing (embryonic day 16 [E16] and E18), post-natal day (P4) and adult MECs (Giraddi et al.,
2018), and scRNA-seq was plotted according to diffusion components (DCs) using software (http://uofuhealth.utah.edu/huntsman/labs/
spike/d3.php) as described previously (Giraddi et al., 2018). DC1 represents a continuum of relative enrichment from basal to luminal
subtype. DC2 represents developmental time from primitive (E16 and E18) to P4 adult mammary cells occupy ends of the DC2 axis.
(B) The abundance of Dach1 transcripts was mapped upon the diffusion map scRNA-seq transcriptomics, in order to show the correlation
with stage of development and relative abundance in the luminal versus basal subtypes. Dach1 is expressed among multipotent fetal
mammary stem cells in the embryo and among mixed lineage precursors prior to puberty Dach1 expression was detected in adult basal cells
(dark blue dots in lower-right corner) and (ERa+) luminal progenitors (light blue dots in upper-right corner).
(C–F) Dach1 RNA transcripts are expressed during post-natal development. (C) scRNA-seq of MECs derived from nulliparous, mid gestation,
lactation, and post-involution mammary glands identified 15 clusters of MECs (Bach et al., 2017). (D) Relative expression of Dach1 within
each cluster type is shown colorimetrically, with relative expression shown in the bar to the right. (E) Dendrogram of clusters based on the
log-transformed mean expression values of the 15 clusters. The red blocks show the cluster subtype in which Dach1 is expressed based on
the relative abundance of transcripts shown in (F). Dach1 gene expression was detectable primarily in presumptive basal and myoepithelial
cells (clusters C12, C13, and C14), and to a lesser degree also in luminal ERa+ (cluster C3) and luminal progenitor clusters (C6/7).
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the expression of genes known to govern the process.
Branching is associated with increased PYGO2 (Gu et al.,
2013), ELF5 (Chakrabarti et al., 2012), PML,NOTCH1 (Bou-
ras et al., 2008), and GATA3 (Asselin-Labat et al., 2007).
Immunohistochemical analysis of the wild-typemammary
gland identified PYGO2 in the luminal cells with occa-
sional basal cells staining, PML in both luminal and epithe-
lial cells, and GATA3 expression in the luminal cells
(indicated with the arrows in Figure 4B). In the Dach1/
mammary gland the abundance of PYGO2, PML, and
GATA3 were reduced (Figures 4B and 4C).
qPCR verified the reduction of Dach1 mRNA (Figure 5A)
and a reduction in the abundance of the mRNA for Gata3,
Elf5, Pml, Notch1, and Pygo2 (Figures 5B–5F) in the
Dach1/ mammary gland. Notch1 mRNA levels were
modestly reduced (Figure 5E). Analysis of DACH1 binding
to these target genes was assessed using chromatin immu-
noprecipitation sequencing conducted on a DACH1 stably
transfected MDA-MB-231 breast cancer cell line (Wu et al.,
2008, 2011). Significant enrichment of DACH1 binding
was identified at the target promoters for Gata3, Elf5, Pml,
Notch1, and Pygo2 (Figures 5G–5L). DACH1 enrichment
was located at the transcriptional start site of each gene,
consistent with the known binding of DACH1 to the tran-
scription elongation regulator (TCERG) (TCERG1, also
known as CA150 or TAF2S) (Zhou et al., 2010a) and at
CTCF sites (Figures 5H–5L).
DACH1 Enhances Ductal Branching in Epithelial
Cultures
LA-7 cells exhibit the normal mammary gland stem cell
properties of self-renewal and multilineage differentiation
in vitro and in vivo (Zucchi et al., 2007). LA-7 cells keep the
potentials to defferentiate to all the epithelial cell types pre-
sent in vivo and, when cultured in 3D collagen matrix,
develop organoids with 3D tubule-alveolar-like structures
that morphologically and functionally recapitulate the 3D
architecture of the mammary tree (Zucchi et al., 2007).
LA-7 cells expressing DACH1 or control cells seeded onto
3D collagen-generated ductal/acinar structures as assessed
by phase contrast microscopy (Figure 6A). Branching
occurred by day 7 and increased through day 14 and subse-
quently (Figure 6A). DACH1-transduced LA-7 cell sprouting
was increased 2.3-fold (Figure 6B, n = 3 experiments,
p < 0.01, day 20). After day 14 in LA-7-DACH1 cells, the tu-
bule structures were converted into lobular structures when
compared with controls (Figure 6A). DACH1 increased
b-casein abundance and reduced CD44 at day 4 when
normalized to the b-actin loading control (Figure 6C). Trans-
fection of LA-7 cells with the DACH1 expression vector
increased DACH1 expression 3-fold, as determined by
qPCR (Figure 6D). RT-PCR analysis showed a 2- to 3-fold in-
crease in the luminalmarkers E-cadherin (CDH1) andCK18,
when normalized to hypoxanthine phosphoribosyl (HPR);
abundance of the surface glycoprotein CD44 was reduced
40% (Figure 6D, p < 0.05). The ductal morphogenesis target
Gata3 was induced 3-fold and Notch1 was induced 4.8-fold
(Figure 6D).
We next examined the impact of DACH1 on the abun-
dance of luminal versus myoepithelial cell lineage markers
during LA-7 cell organoid formation using immunofluores-
cence. LA-7 cells transfected with DACH1 or with empty
vector as a control, were cultured in collagen for 10 days
and then digested with collagenase. The 3D structures
were then embedded in OCT and sectioned with a cryo-
tome. Organoids generated by LA-7 in which DACH1 was
transfected express epithelial luminal markers (CDH1)
but less of the myoepithelial markers (CK14) (Figures 6E
and S5).
Because endogenous DACH1 enhanced the proportion
of Lin CD24med CD29high, which we herein referred to
as basal cells, we considered the possibility that DACH1
may drive the expansion of MaSCs and therefore deployed
a surrogate assay of mammosphere formation using LA-7
cells. DACH1 transduction of LA-7 cells increased mam-
mosphere number by 30% (Figures 6F and 6G, n = 3 sepa-
rate experiments, p < 0.01). Transduction efficiency of the
LA-7 cells was 70%–80%. Thus, DACH1 promotes forma-
tion of mammary gland ducts and mammospheres in
LA-7 cells.
Figure 3. Dach1 Gene Deletion Reduces Mammary Gland Cellular Proliferation, Ductal Branching, and Myoepithelial/Stem Cells
(A) Cellular proliferation assessed by Ki-67 immunostaining with nuclei marked by DAPI staining (A).
(B) As above, but quantified as mean ± SEM for n = 3 separate mice in each group. Data are shown for Dach1wt/wtROSA26CreERT2/mTmGfl versus
Dach1fl/flROSA26CreERT2/mTmGfl after tamoxifen treatment as shown in Figure 1A.
(C) Ductal branching analysis (shown as mean ± SEM for n = 3 mice). Representative examples are shown at high magnification in
Figure S3.
(D) A representative fluorescence-activated cell sorting (FACS) analysis from the mammary epithelium showing the separation of mT from
mG cells, the subsequent separation of Lin cells and the apportioning of CD24/CD29 status.
(E) The proportion of Lin cells (cells from mammary gland excluding vascular and hematopoietic cells) was determined by FACS analysis
and quantified for n = 4 separate mice. The proportion of Lin cells was not significantly altered between genotypes.
(F) The percentage of LinCD24medCD29hi cells was determined upon FACS analysis for n = 4 separate mice in each group.
(G) Luminal epithelial cells are shown as LinCD24hi CD29lo with data as mean ± SEM for n = 4 separate mice.
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DACH1 Restrains TGF-b Action in the Pubertal
Mammary Gland In Vivo
The TGF-b signaling pathway restrains mammary progeni-
tor self-renewal (Martinez-Ruiz et al., 2016) and lineage
commitment decisions, decreasing myoepithelial cell pro-
genitors (Lindley and Briegel, 2010; Martinez-Ruiz et al.,
2016). Furthermore, TGF-b is known to restrain mammary
ductal branching (Bottinger et al., 1997; Daniel and Robin-
son, 1992; Moses and Barcellos-Hoff, 2011; Nelson et al.,
2006; Pierce et al., 1993) (Figure 7A). We therefore deter-
mined the possible role of endogenousDach1 in restraining
mammary gland TGF-b activity by first assessing the phos-
phorylation of SMADs. Immunohistochemical staining
demonstrated increased phosphorylation of SMAD 2/3
and SMAD 1/5/8 in both the basal and luminal MECs (Fig-
ures 7B–7E).
DACH1 Inhibits SMADAssociationwith Smad Anchor
for Receptor Activation
Reintroduction of DACH1 via a retroviral expression vector
into the metastatic Met-1 breast cancer cell line, increased
DACH1 abundance and reduced Smad anchor for receptor
activation (SMAD) 2/3 phosphorylation (Figure 7F) and
SMAD 1/5/8 phosphorylation (Figure 7G) in both the nu-
clear and cytoplasmic fractions. The scaffold protein
SARA, also known as the zinc finger FYVE domain-contain-
ing protein 9 (ZFYVE9), brings SMAD 2/3 to TGF-b recep-
tors, facilitating SMAD 2/3 activation and thereby aug-
menting TGF-b signaling (Tsukazaki et al., 1998). The
relative abundance of SARA was increased 4-fold upon
Dach1 deletion (Figure 7H). Immunoprecipitation (IP)
with an antibody directed to SMAD 2/3 co-precipitated
SARA; however, the relative abundance of SARA in the
SMAD 2 IP was dramatically increased in the Dach1/
cells, consistent with a role for DACH1 to inhibit the
SARA-SMAD 2/3 association and thereby reduce basal
SMAD activity (Figures 7H, S6B, and S6C).
DISCUSSION
DACH1 SkewsMammaryGland Lineage Development
In this current study, we show that endogenous DACH1 in-
creases the proportion of basal cells and reduces the propor-
tion of luminal cells in the post-natal mammary gland.
Interrogation of Dach1 transcripts from scRNA-seq (Gir-
addi et al., 2018; Latha and Saddala, 2017) demonstrated
that Dach1 gene expression was detectable in multiple
lineages and stages, including multipotent fMaSCs in
the embryo and among MMPr prior to puberty. DACH1
expression was detected in presumptive basal and myoepi-
thelial cells, adult basal cells and (ERa+), luminal progeni-
tor, and in ERa+ luminal cells. The mechanism by which
DACH1 alters the relative proportion of basal versus
luminal cells may involve lineage skewing during differen-
tiation, intrinsic effects in different lineage progenitors, or
transitive effects from myoepithelial cells that normally
restrain the luminal cell number in a juxtacrine/paracrine
fashion and may involve both cell intrinsic or heterotypic
signaling.
What might be the consequence of DACH1 increasing
the proportion of basal cells? Myoepithelial cells express a
variety of recognized tumor-suppressor proteins (p63,
p73, 14-3-3-s, and maspin) and provide the interface be-
tween tumor cells of ductal carcinoma in situ and the
microenvironment (Pandey et al., 2010b), conveying anti-
angiogenic, antiproliferative, and anti-invasive properties.
Previous studies have shown that DACH1 reduced growth
of breast tumor cells in tissue culture and in immune-defi-
cientmice (Popov et al., 2009, 2010;Wu et al., 2006, 2011).
Collectively, these studies suggest that DACH1 is required
for normal myoepithelial cell number and function and
may thereby play a regulatory role as ‘‘natural tumor sup-
pressors’’ in the mammary gland (reviewed in Adriance
et al., 2005; Bissell and Labarge, 2005; Lakhani and
O’Hare, 2001; Pandey et al., 2010a; Sternlicht and Barsky,
1997; Sternlicht et al., 1997).
DACH1 Promotes Mammary Gland Ductal Branching
The current studies demonstrate that Dach1 deletion
reduced mammary gland ductal branching and DACH1
expression in LA-7 cells enhanced ductal branching. Prior
studies demonstrated a role for DACH1 in promoting
migration in several different cell types including fibro-
blasts (Wu et al., 2008), MECs (Wu et al., 2008), prostate
epithelial cells (Chen et al., 2015), and vascular endothelial
cells (Chang et al., 2017). TGF-b1 is a major negative regu-
lator of mammary ductal branching, restricting end bud
bifurcation and branch formation (Ewan et al., 2002; Ing-
man and Robertson, 2008; Silberstein and Daniel, 1987).
Figure 4. Dach1 Gene Deletion Reduces the Abundance of Mammary Gland Stem Cell and Ductal Cell Lineage Gene Targets
(A) Immunofluorescent double staining for cytokeratin 5 (CK5) and CK8 showed that Dach1 gene deletion decreases the relative amount of
CK5-positive cells versus CK8-positive cells.
(B) Immunohistochemical staining for differentiation factors (Gata3, Pml, and Pygo2) in the mammary gland of Dach1+/+ versus Dach1/
(Cre deletion mice) (Dach1wt/wtROSA26CreERT2/mTmGfl versus Dach1fl/flROSA26CreERT2/mTmGfl). The red arrowheads indicate basal epithelial
cells.
(C) Quantitation of immunohistochemical staining shown as mean ± SEM for n = 3 separate mice.
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Figure 5. DACH1 Occupies the Promoter Regions of Mammary Gland Stem Cell and Ductal Cell Lineage Gene Targets
(A–F) qRT-PCR analysis of mRNA for genes participating in mammary gland stem cell and ductal development, (A) Dach1, (B) Gata3, (C)
Elf5, (D)Pml, (E) Notch1, and (F) Pygo2, in the mammary gland of Cre deletion mice (Dach1wt/wtROSA26CreERT2/mTmGfl versus Dach1fl/fl
ROSA26CreERT2/mTmGfl) with quantitation shown as mean ± SEM for n = 3 separate mice. Notch1 mRNA levels were modestly reduced in the
Dach1/ mammary gland.
(G–L) Analysis of DACH1 binding to these target genes was assessed using chromatin immunoprecipitation sequencing assays conducted
on DACH1 stable MDA-MB-231 cells (G). (H) Gata3, (I) Elf5, (J) Pml, (K) Notch1, and (L) Pygo2.
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Epithelial cell or stromal expression of a dominant-nega-
tive TGF-b allele (dnIIR) increased mammary ductal
branching (Bottinger et al., 1997). Dach1 deletion pheno-
copies TGF-b overactivity. The finding that Dach1 gene
deletion phenocopies TGF-b over activity, and that Dach1
deletion results in TGF-b hyperactivity demonstrated by
increased SMAD phosphorylation in the mammary gland,
suggests that Dach1-mediated TGF-b restraint may govern
the mammary gland ductal branching phenotype. SMAD
phosphorylation was increased in both the basal and
luminal cells. DACH1 was expressed in both basal and
luminal cells during development; however, in the adult
mammary gland, immunohistochemistry showed that
DACH1 was predominantly in the basal cells, raising the
possibility that Dach1 exerts both cell-autonomous and
non-autonomous effects on TGF-b signaling.
Several other genes are essential for normal mammary
duct development including Esr1, Srib, and Ovol2, and pu-
bertal branching development is disrupted in mice lacking
GH, insulin-like growth factor 1 (Igf1), or estrogen receptor a
(Esr1). DACH1 can inhibit IGF1 and ERa signaling to
restrain EMT (DeAngelis et al., 2011; Popov et al., 2009;
Wu et al., 2011), which may contribute to the mammary
gland developmental changes of Dach1/ mice.
DACH1 Expands the Mammary Gland Stem Cell
Population
Herein DACH1 enhanced LA-7 cell mammosphere forma-
tion and endogenous Dach1 enhanced the proportion of
basal cells, characterized by CD24medCD29hiLin cells,
in vivo. The expansion of the basal cell population may
be secondary to the restraint of TGF-b activity, as TGF-b de-
creases MEC repopulating activity (Martinez-Ruiz et al.,
2016). Alternatively the expansion may be secondary to
transcriptional effects by Dach1 on several target genes
known to participate in the expansion ofMaSCs, including
PYGO2, NOTCH1, and BRCA1 (Gu et al., 2013; Martinez-
Ruiz et al., 2016; Visvader and Stingl, 2014) (Figures S6B
and S6C). PML serves to enhance the transition of luminal
progenitors to alveolar progenitors, which may in turn in-
crease the myoepithelial progenitor pool. The histone
methylation reader PYGO2, a coactivator of the WNT
pathway, is necessary for suppressing luminal and alveolar
differentiation of the MaSC-enriched population by coor-
dinating the activity of the Wnt and Notch pathways (Gu
et al., 2013). GATA3 is a crucial regulator of the luminal
lineage as GATA3 restrains luminal progenitors (Asselin-
Labat et al., 2007). Herein DACH1 enhanced basal cells
and restrained TGF-b activity, and TGF-b is known to
restrain basal cell expansion. The frequency of basal cells
and the development of breast cancer subtypes suggests
that inactivation of lineage determinant proteins aremech-
anistically linked (Visvader and Stingl, 2014). The current
studies contrast with findings that Dach1 restrains breast
cancer (Wu et al., 2011) and brain cancer (Watanabe
et al., 2011) stem cells. These findings may reflect the
dual effects of TGF-b early in the mammary gland as a tu-
mor suppressor and at a later stage to evade immune sur-
veillance and promote metastasis (Massague, 2008, 2012).
EXPERIMENTAL PROCEDURES
Transgenic Mice
All the animal studies were approved by the Institutional Animal
Care and Use Committee of Thomas Jefferson University. The
Dach1fl/fl mice (Chen et al., 2015; Pierce et al., 1993) (which re-
move the same section of the Dach1 locus that is deleted in the
knockout mice strain [Davis et al., 2001]), were intercrossed
with the ROSA26CreERT2 mice (expressing CRE-ERT2 fusion protein
under the control of the ubiquitous ROSA26 promoter; the
mice were kindly provided by Dr. Thomas Ludwig at Columbia
University, New York, NY). Dach1fl/fl mice were mated with
either ROSA26CreERT2/CreERT2 or ROSA26mTmG/mTmG mice to
generate Dach1fl/wtROSA26CreERT2/CreERT2 (Cre mice) and Dach1fl/wt
ROSA26mTmG/mTmG (Cre reporter mice). Dach1fl/wtROSA26CreERT2/+
Figure 6. DACH1 Induces Ductal Branching and Mammospheres in LA-7 Cells
(A) Representative phase contrast microscopy images of LA-7 cells cultured on collagen plates (upper panels), LA-7 cells transduced with
control vector (middle panel), or vector-expressing DACH1 (lower panels) are shown.
(B and C) Cells were analyzed for ductal formation at day 20 (B). LA-7 tubule sprout number per view shown as mean ± SEM (C). Western
blot with antibodies as indicated of either LA-7 cells transduced with control vector or DACH1 expression vector. b-Actin is used as a
protein loading control.
(D) RT-PCR analysis of mammary stem cell regulatory genes was conducted. Results are shown as mean ± SEM for n = 3 separate exper-
iments. *p < 0.05.
(E) Immunofluorescence of LA-7 cells transfected with DACH1 or with empty vector, grown in 3D organoids structures. DACH1 reduced
myoepithelial markers (CK14, green), whereas luminal markers (CDH1) were upregulated.
(F) LA-7 cells, or LA-7 cells transduced with control vector or vector expressing DACH1, were analyzed for mammosphere formation. Cells
were plated in limiting dilutions of 500 cells/1.4 mL of media and mammosphere (150–200 cells) were counted at day 8. Phase contrast
image of a representative field is shown and the number of mammospheres (mean ± SEM is shown for n = 3 separate experiments,
*p < 0.01).
(G) A separate clone of LA-7 cells transduced with DACH1 or vector control were grown as mammospheres in 24-well plates and
representative images are shown at 23.
146 Stem Cell Reports j Vol. 12 j 135–151 j January 8, 2019
(legend on next page)
Stem Cell Reports j Vol. 12 j 135–151 j January 8, 2019 147
mice were then mated with Dach1fl/wtROSA26mTmG/+ mice to
generate Dach1fl/flROSA26CreERT2/mTmG mice and Dach1wt/wt
ROSA26CreERT2/mTmG littermates.
Immunohistochemistry, Immunofluorescence, and
TUNEL Staining
Immunohistochemical analysis of paraffin-embedded murine
mammary gland tissues was conducted using a polyclonal
DACH1 antibody (Proteintech, cat. no. 10,914-1-AP) (Wu et al.,
2006), anti-PYGO2 (Thermo Fisher Scientific, cat no. PA5-34878),
anti-PML1 (Abcam, cat. no ab67761), anti-GATA3 (Santa Cruz
Biotechnology, cat. no, sc-9009), anti-vWF (A0082, Dako), anti-
phosphorylated SMAD2/3 (Santa Cruz Biotechnology, cat. no.
sc-11769-R), or anti-phosphorylated SMAD1/5/8 (Ser 423/425)
(Santa Cruz Biotechnology, cat. no. sc-12353-R). Immunofluores-
cent analysis of frozen mouse mammary gland was conducted
using anti-Ki-67 clone SP6 rabbit monoclonal antibody (Abcam,
cat. no. ab16667), anti-CK5 antibody (PRB-160P, Covance), rabbit
polyclonal and/or anti-CK8 mouse monoclonal antibody (MMS-
162P, Covance). DAPI was used as counter staining. Alexa Fluor
633- or Alexa Fluor 565-conjugated goat anti-rabbit antibody and
Alexa Fluor 488-conjugated goat anti-mouse antibody were
used as secondary antibodies (Jiao et al., 2008; Ju et al., 2013).
Frozen sections of murine mammary gland tissues were used in
immunofluorescence TUNEL staining. E-cadherin-FITC conju-
gated raised in mouse (BD Bioscience, cat no. 612131), cytokeratin
14 raised in rabbit (Sigma cat no. HAPA023040), and the secondary
antibody raised in goat against rabbit IGG Alexa Fluor 488
(Life Technologies, cat no. A11034) were used in LA-7 cell
immunofluorescence.
Cell Culture, Reagents, Mammosphere Assays,
Expression Vectors, DNA Transfection, and Statistical
Analyses
The generation and culture of 3T3 and mouse embryonic fibro-
blasts derived from Dach1/ mice, the Met-1 breast cancer cell
line (Wu et al., 2008, 2011), and LA-7 rat mammary gland stem
cells (Zucchi et al., 2007) were described previously (Wu et al.,
2008, 2011). TGF-b was obtained from Calbiochem. Met-1 cells
were infected with either MSCV-IRES-GFP (murine stem cell
virus) or MSCV-DACH1-IRES-GFP (Wu et al., 2006). LA7 cells
were transiently transfected with Amaxa system (Amaxa Nucleo-
fector Kit, Lonza) according to the manufacturer’s protocol.
1 3 106 LA7 cells were tansfected with 2 mg of each plasmid
(GFP-empty, pKW-empty, and pKW-DACH1). GFP-plasmid was
used as endogenous control of transfection. Data were expressed
as the means ± SEM. Statistical analyses were performed using the
Student’s t test, and p values were <0.05.
Tubule and Organoid Formation in 3D Culture
For tubule/organoid formation, cells were suspended on ice in rat
tail-derived collagen prepared as described previously (Zucchi
et al., 2007). Organoid cultures were examined daily with light
microscopy to assess tubule and organoid formation and photo-
graphed at days 7, 14, and 20. Evaluation of branching was
assessed 3 days after seeding by examining 10 tubules for each con-
dition in 3 independent experiments.
IP and Western Blot
IP and western blot assays were performed in cells as indicated. For
each IP, 1mL lysate (1mgprotein) and 2 mg anti-SMAD2/3 (BD, cat.
no. 610843) or anti-SARA (Proteintech, cat. no. 14821-1-AP) were
incubated overnight at 4C. Immunoprecipitates were washed 5
times in IP buffer, and 30 mL of 23 sample buffer was added to
the bead pellet. Laminin B1 antibody (Abcam, cat. no. ab16048)
was used as an internal control for nuclear protein abundance
and vinculin (Sigma, cat. no. V9131) was used as a control for cyto-
plasmic fraction enrichment. Polyclonal anti-Beta casein (Santa
Cruz, cat no. SC-30042), monoclonal anti CD44 (Santa Cruz cat
no. SC-53068), and polyclonal anti-Beta actin (Santa Cruz, cat
no. SC-1615) were used in LA-7 cell Western-blot.
FACS Analysis of Stem Cells
FACS analysis for mammary epithelial stem cells was conducted as
outlined in prior publications (dos Santos et al., 2013; Jiao et al.,
2016; Shackleton et al., 2006). In brief, mammary glands were
removed from 12-week-old Dach1fl/flROSA26CreERT2/mTmG and
Dach1wt/wtROSA26CreERT2/mTmG mice. Both strains of mice were
treatedwith a 5-day pulse of tamoxifenwhenmice reached 6weeks
of age and were analyzed after a subsequent 2.5 months. The data
were analyzed with FlowJo single-cell analysis software (Tree Star,
Ashland, OR).
Real-Time qPCR
PCR analysis for luminal markers (Cdh1 [E-cadherin]), CK18, alve-
olar marker (b-casein), and CD44 was conducted of LA-7 mRNA as
Figure 7. Dach1 Gene Deletion Activates TGF-b Signaling in the Mammary Gland
(A) A summary of the mammary gland phenotype identified herein upon Dach1 gene deletion, with comparison to the effect of TGF-b gene
deletion summarized from the literature (Daniel and Robinson, 1992; Moses and Barcellos-Hoff, 2011; Bottinger et al., 1997; Nelson et al.,
2006; Pierce et al., 1993).
(B and C) Representative example (B) and quantitative analysis (C) of immunohistochemical staining for pSMAD2/3 in the mammary gland
from mice shown as Dach1+/+ (Dach1wt/wtROSA26CreERT2/mTmGfl) and DACH1–/– (Dach1fl/flROSA26CreERT2/mTmGfl).
(D and E) Representative example of immunostaining for pSMAD 1/5/8 (D), with quantification (E) shown as mean ± SEM for n = 3 separate
animals.
(F and G) Western blots of Met-1 breast cancer cells transduced with a DACH1 expression vector using antibodies to the proteins as
indicated (F) for p-SMAD2/3 and (G) for DACH1, p-SMAD1/5/8, and Cyclin D1.
(H) Western blot of Dach1wt versus Dach1/ 3T3 cells for SARA association after immune precipitation for Smad 2/3. S.E., short exposure;
L.E., longer exposure. b-Actin is used as a protein loading control.
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described previously (Zucchi et al., 2007). Primers for all the genes/
gene transcripts including 18s rRNA and HPRT (hypoxanthine-
guanine phosphoribosyltransferase) transferase are listed in Table
S1, except Cdh1, CK18, and CD44 which described previously
(Zucchi et al., 2007).
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